The Motley Fool

MESOBLAST FPO (ASX: MSB) Share Price and News

 Chart and Price Data

20mins delayed

.

Price
Bid/Ask /
Volume
Avg Daily Volume
Day Movement
Day High/Low /
52 Week Range -
Year Return (Capital)
As at
Please Wait...

MESOBLAST FPO (ASX: MSB) Latest News

racing higher

Why Blackmores, Class, Mesoblast, & St Barbara shares raced higher today

The Blackmores Limited (ASX:BKL) share price and the Mesoblast limited (ASX:MSB) share price are two of four racing higher on Thursday... More »


business share price

Why Mesoblast, New Hope, Pilbara Minerals, & Syrah shares charged higher today

The Mesoblast limited (ASX:MSB) share price and the Syrah Resources Ltd (ASX:SYR) share price are two of four charging notably higher today... More »


Paradigm share price tanks despite positive clinical trial update

Paradigm Biopharmaceuticals Ltd (ASX: PAR) is a speccy biotech that could sink or soar. More »


Rocket soaring through the sky

Why the Mesoblast share price is going nuts today

Mesoblast limited (ASX: MSB) has signed an important partnership with Grünenthal. More »


share price higher

Why iSignthis, Leigh Creek, Mesoblast, & Santos shares charged higher

The iSignthis Ltd (ASX:ISX) share price and the Mesoblast limited (ASX:MSB) share price are two of four charging higher on Tuesday... More »


Mesoblast share price rockets 17% higher on Grünenthal partnership news

The Mesoblast Limited (ASX:MSB) share price has rocketed higher on Tuesday following the release of a positive update relating to its MPC-06-ID product... More »


bull and bear figurines facing off over stockmarket graph

Opthea share price lifts on clinical trial update: Is it a spec buy?

Opthea Ltd (ASX: OPT) is developing clinical treatments for eye diseases. More »


healthcare shares

Mesoblast share price edges higher on quarterly update

The Mesoblast Ltd (ASX: MSB) share price closed 0.6% higher on the ASX yesterday after the company reported its June 2019 quarterly update. More »


Businessman paying Australian money

Biotech speccy Paradigm is being tipped for the big time

Paradigm (ASX: PAR) has $78 million cash on hand and a goal to commercialise osteoarthritis drugs. More »


Dive

High profile fundie warns these 10 ASX shares have “bubble” valuations

Bubs Australia Ltd (ASX: BUB), Audinate Group Ltd (ASX: AD8) and other popular shares are in the firing line. More »


dividend trap

Telix Pharmaceuticals just boasted it’s one step closer to getting a cancer treatment approved

Telix Pharmaceuticals Ltd (ASX:TLX) could hand investors huge gains or losses. More »


pharmaceutical shares

Is the Starpharma share price a buy?

The Starpharma Holdings Limited (ASX: SPL) share price has gained 50% since the end of December 2018. Is it a buy? More »


beat the share market

Why Adairs, Ausdrill, Domino’s, & Mesoblast shares charged higher today

The Ausdrill Limited (ASX:ASL) share price and the Domino's Pizza Enterprises Ltd (ASX:DMP) share price are two of four starting the week on a... More »


Why the Mesoblast share price zoomed 7% higher today

The Mesoblast Limited (ASX:MSB) share price has been on fire on Monday. Here's why... More »